Jump to ContentJump to Main Navigation
Show Summary Details
More options …

International Journal of Adolescent Medicine and Health

Editor-in-Chief: Merrick, Joav

Editorial Board: Birch, Diana ML / Blum, Robert W. / Greydanus, MD, Dr. HC (Athens), Donald E. / Hardoff, Daniel / Kerr, Mike / Levy, Howard B / Morad, Mohammed / Omar, Hatim A. / de Paul, Joaquin / Rydelius, Per-Anders / Shek, Daniel T.L. / Sher, Leo / Silber, Tomas J. / Towns, Susan / Urkin, Jacob / Verhofstadt-Deneve, Leni / Zeltzer, Lonnie / Tenenbaum, Ariel


CiteScore 2018: 0.79

SCImago Journal Rank (SJR) 2018: 0.350
Source Normalized Impact per Paper (SNIP) 2018: 0.476

Online
ISSN
2191-0278
See all formats and pricing
More options …
Volume 31, Issue 3

Issues

Pubertal gynecomastia: years of progress – the Hacettepe experience

Sinem Akgül
  • Division of Adolescent Medicine, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Orhan Derman
  • Division of Adolescent Medicine, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nuray Kanbur
  • Corresponding author
  • Division of Adolescent Medicine, Department of Pediatrics, Hacettepe University Faculty of Medicine, Sihhiye, 06100 Ankara, Turkey, Tel.: 0312-3051160
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2017-06-09 | DOI: https://doi.org/10.1515/ijamh-2017-0011

Abstract

Gynecomastia is defined as an enlargement of the male breast. Although it is commonly seen during puberty, it is often overlooked by many physicians. As adolescent medicine specialists, we believe there is a gap in the literature concerning both the etiology and maybe more importantly the care of these adolescents. Thus, we have been dedicated to conducting research on this topic. The aim of this review article was to evaluate the studies concerning pubertal gynecomastia that took place at the Division of Adolescent Medicine, Hacettepe University, published between the years 2003 and 2016. The review covers in detail both the short- and long-term effectivity and safety of tamoxifen used for the treatment of pubertal gynecomastia. As the exact basis for the pathogenesis of gynecomastia remains unknown, we also evaluate three studies that aimed to answer this question. We additionally review a study that aimed to assess the psychological distress and effect on body image that gynecomastia may have on the adolescent male. An important contribution this review article adds to the literature is as a conclusion to all the studies performed, we present the ‘Hacettepe indications for tamoxifen treatment for pubertal gynecomastia’. These indications will aid physicians when considering treating these patients.

Keywords: etiology; pubertal gynecomastia; tamoxifen; treatment

  • [1]

    Akgül S, Kanbur N, Derman O. A different training model for adolescent medicine: a PhD program in Turkey, where adolescent medicine is not currently a sub-specialty at this stage. Int J Adolesc Med Health. 2016;28(3):269–72.PubMedCrossrefGoogle Scholar

  • [2]

    Carlson HE. Gynecomastia. N Engl J Med. 1980;303(14):795–9.CrossrefPubMedGoogle Scholar

  • [3]

    Braunstein GD. Gynecomastia. N Engl J Med. 2007;357(12):1229–37.PubMedCrossrefGoogle Scholar

  • [4]

    Boljanovic S, Axelsson C, Elberg J. Surgical treatment of gynecomastia: liposuction combined with subcutaneous mastectomy. Scand J Surg. 2003;92(2):160–2.CrossrefPubMedGoogle Scholar

  • [5]

    Lawrence SE, Arnold Faught K, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr. 2004;145(1):71–6.CrossrefPubMedGoogle Scholar

  • [6]

    Riepe FG, Baus I, Wiest S, Krone N, Sippell WG, Partsch C-J. Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole. Horm Res. 2004;62(3):113–8.PubMedGoogle Scholar

  • [7]

    Lapid O, van Wingerden JJ, Perlemuter L. Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review. J Pediatr Endocrinol Metab. 2013;26(9-10):803–7.Web of SciencePubMedGoogle Scholar

  • [8]

    Wood AJ, Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339(22):1609–18.CrossrefPubMedGoogle Scholar

  • [9]

    Derman O, Kanbur NÖ, Kutluk T. Tamoxifen treatment for pubertal gynecomastia. Int J Adolesc Med Health. 2003;15(4):359–64.PubMedGoogle Scholar

  • [10]

    Derman O, Kanbur N, Kınıç I, Kutluk T. Long-term follow-up of tamoxifen treatment in adolescents with gynecomastia. J Pediatr Endocrinol Metab. 2008;21(5):449–54.PubMedGoogle Scholar

  • [11]

    Derman O, Kanbur N, Tokur TE. The effect of tamoxifen on sex hormone binding globulin in adolescents with pubertal gynecomastia. J Pediatr Endocrinol Metab. 2004;17:1115–20.PubMedGoogle Scholar

  • [12]

    Kilic M, Kanbur N, Derman O, Akgül S, Kutluk T. The relationship between pubertal gynecomastia, prostate specific antigen, free androgen index, SHBG and sex steroids. J Pediatr Endocrinol Metab. 2011;24(1-2):61–7.PubMedWeb of ScienceGoogle Scholar

  • [13]

    Durmaz E, Özmert EN, Erkekoğlu P, Giray B, Derman O, Hıncal F, et al. Plasma phthalate levels in pubertal gynecomastia. Pediatrics. 2010;125(1):e122–9.PubMedCrossrefWeb of ScienceGoogle Scholar

  • [14]

    Pehlivantürk Kızılkan M, Akgül S, Akbıyık F, Derman O, Kanbur N. Evaluation of serum vitamin D levels in adolescents with pubertal gynecomastia. Breast Care. 2016;11:333–7.Web of ScienceCrossrefGoogle Scholar

  • [15]

    Akgül S, Kanbur N, Güçer Ş, Şafak T, Derman O. The histopathological effects of tamoxifen in the treatment of pubertal gynecomastia. J Pediatr Endocrinol Metab. 2012;25:753–5.PubMedWeb of ScienceGoogle Scholar

  • [16]

    Akgül S, Derman O, Kanbur N. The effect of tamoxifen on pubertal bone development in adolescents with pubertal gynecomastia. J Pediatr Endocrinol Metab. 2016;29:77–83.PubMedWeb of ScienceGoogle Scholar

  • [17]

    Esenboğa S, Akgül S, Kanbur N, Tüzün Z, Derman O. The effect of gynecomastia on body image perception and gender roles in adolescents. Turk J Pediatr. 2015;57:60–7.PubMedGoogle Scholar

  • [18]

    Love RR. Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects. J Clin Oncol. 1989;7(6):803–15.CrossrefPubMedGoogle Scholar

  • [19]

    Sawka CA, Pritchard KI, Paterson AH, Sutherland DJ, Thomson DB, Shelley WE, et al. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma. Cancer Res. 1986;46(6):3152–6.PubMedGoogle Scholar

  • [20]

    Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem. 1990;27(6):532–41.CrossrefPubMedGoogle Scholar

  • [21]

    Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod. 2011;85(3):431–41.PubMedWeb of ScienceCrossrefGoogle Scholar

  • [22]

    Kim M, Gupta M, Travers S, Rogers D, Van Lente F, Faiman C. Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys. Clin Endocrinol. 1999;50(2):203–10.CrossrefGoogle Scholar

  • [23]

    Vieira J, Nishida S, Pereira A, Arraes R, Verreschi I. Serum levels of prostate-specific antigen in normal boys throughout puberty. J Clin Endocrinol Metab. 1994;78(5):1185–7.PubMedGoogle Scholar

  • [24]

    Zoeller RT, Brown T, Doan L, Gore A, Skakkebaek N, Soto A, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine society. Endocrinology. 2012;153(9):4097–110.CrossrefWeb of SciencePubMedGoogle Scholar

  • [25]

    Shea KM. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics. 2003;111(6):1467–74.CrossrefPubMedGoogle Scholar

  • [26]

    Sibonga JD, Evans GL, Hauck ER, Bell NH, Turner RT. Ovarian status influences the skeletal effects of tamoxifen in adult rats. Breast Cancer Res Treat. 1996;41(1):71–9.PubMedCrossrefGoogle Scholar

  • [27]

    Kinsella C, Landfair A, Rottgers SA, Cray JJ, Weidman C, Deleyiannis FW, et al. The psychological burden of idiopathic adolescent gynecomastia. Plast Reconstr Surg. 2012;129(1):1–7.PubMedCrossrefWeb of ScienceGoogle Scholar

  • [28]

    Alagaratnam T. Treating puberty gynecomastia. JR Coll Gen Pract. 1987;37(297):178.Google Scholar

  • [29]

    Atabek ME. Gynecomastia in puberty is usually asymptomatic and regresses spontaneously. J Pediatr Endocrinol Metab. 2013;26(5-6):605.PubMedWeb of ScienceGoogle Scholar

About the article

Received: 2017-01-21

Accepted: 2017-02-28

Published Online: 2017-06-09


Conflict of interest statement: The authors declare that they have no conflict of interest.


Citation Information: International Journal of Adolescent Medicine and Health, Volume 31, Issue 3, 20170011, ISSN (Online) 2191-0278, DOI: https://doi.org/10.1515/ijamh-2017-0011.

Export Citation

© 2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in